Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy.
about
Immunomodulatory Function of the Tumor Suppressor p53 in Host Immune Response and the Tumor MicroenvironmentTumor-Derived Exosomes and Their Role in Tumor-Induced Immune SuppressionImmunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?Stemness in Cancer: Stem Cells, Cancer Stem Cells, and Their Microenvironment.Adipose-derived mesenchymal stem cells promote osteosarcoma proliferation and metastasis by activating the STAT3 pathway.T cells in multiple myeloma display features of exhaustion and senescence at the tumor site.Tissue-Associated Bacterial Alterations in Rectal Carcinoma Patients Revealed by 16S rRNA Community Profiling.Advances in Immunotherapy for Glioblastoma Multiforme.RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cellsThe cryo-thermal therapy eradicated melanoma in mice by eliciting CD4+ T-cell-mediated antitumor memory immune response.Acid-sensing ion channels contribute to the effect of extracellular acidosis on proliferation and migration of A549 cells.Microengineered cancer-on-a-chip platforms to study the metastatic microenvironment.Molecular mechanisms of HLA class I-mediated immune evasion of human tumors and their role in resistance to immunotherapies.Epigenetic control of the tumor microenvironment.Resistance to immunotherapy: clouds in a bright sky.Targeting the Tumor Stroma: the Biology and Clinical Development of Pegylated Recombinant Human Hyaluronidase (PEGPH20).Partially exhausted tumor-infiltrating lymphocytes predict response to combination immunotherapy.Measuring the immune system: a comprehensive approach for the analysis of immune functions in humans.Driving better and safer HER2-specific CARs for cancer therapy.Tracing and targeting cancer stem cells: New venture for personalized molecular cancer therapy.HALO-109-301: a Phase III trial of PEGPH20 (with gemcitabine and nab-paclitaxel) in hyaluronic acid-high stage IV pancreatic cancer.Immune microenvironment of experimental rat C6 gliomas resembles human glioblastomas.Phenotypic and clinical characterization of low density neutrophils in patients with advanced lung adenocarcinoma.Cancer immunotherapy beyond immune checkpoint inhibitors.Intratumoral delivery of tumor antigen-loaded DC and tumor-primed CD4+ T cells combined with agonist α-GITR mAb promotes durable CD8+ T-cell-dependent antitumor immunity.Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies.Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer.Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning.Mechanisms of rapid cancer cell reprogramming initiated by targeted receptor tyrosine kinase inhibitors and inherent therapeutic vulnerabilities.Local Activation of p53 in the Tumor Microenvironment Overcomes Immune Suppression and Enhances Antitumor Immunity.Showing the Way: Oncolytic Adenoviruses as Chaperones of Immunostimulatory Adjuncts.Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy.Microglia/Astrocytes-Glioblastoma Crosstalk: Crucial Molecular Mechanisms and Microenvironmental FactorsCancer: Precision T-cell therapy targets tumours
P2860
Q28071935-CDA28D0F-7C00-48F1-B14A-2D4321B506ACQ28076769-E575990C-72CC-4FDF-A5C7-D9EDB55D0620Q28078539-C7881A3A-D249-480A-BE03-D2DE3017DF60Q33572252-9AEC45D4-9039-40FD-9756-3357E42917E9Q33618863-8E876069-FBA0-47C5-8322-5D5E56CB5E95Q37390723-AEA9796D-B54A-4430-9435-80A524F41966Q37486656-1D3434D7-2564-4AC0-B654-DB1442899AA5Q37680966-F448A0B1-C617-4863-AF32-B776031E0CAAQ37684367-C663FFFC-375E-4229-8097-0D38D911CFD0Q37745399-62E647A0-7C8C-4FEB-A8A1-0B8CE3DC38ABQ38700194-BE176DF7-CA39-48B6-853C-B40F9AF55646Q38810462-2961B9F8-8D84-461A-8F4F-743FE55A384AQ38962024-1594897A-DE07-4CEA-A91E-10BBEB52A908Q38971785-6299BCC4-15AF-4EDB-9395-CAA57EE517B8Q39236810-56D01674-25A3-4E99-8976-D63A3CF0C7B4Q39356378-9F0438B8-FF0E-4820-9DE8-F78B1A31F106Q40115962-692B7491-313C-4C7C-9A57-2150CB908E68Q40576699-CE10BD79-B846-401F-94B1-7F803F057F61Q41835996-F5872AA1-F29B-4220-BAA5-F10739879CD3Q43258268-003B7363-D04F-4C3D-B185-926D11357141Q46180368-6FE3E5A7-1705-492E-AD99-C4406A0F9B51Q47135965-C8B20F3F-EF21-48C3-A135-0983C72D1374Q47157214-BB82814F-167A-432E-9FFA-47E2CAA7DE26Q47554248-878EFDA6-C9B8-429B-A1F9-881BA37F03E2Q48170351-B4938B24-128F-40F6-B126-F03B2D44920AQ48308048-CA5919CD-9E1F-4CDB-9F8D-6F559A9E8BB2Q48319209-3C9DFDF9-30A4-4021-913A-111A4EA0853DQ49283462-58608CA7-DA20-4DE9-9D0D-174529B282BAQ49843607-85618B8D-9C75-46E0-B9E8-AAF1B45ADFBDQ50676824-83A2917F-6DD6-40F7-8FE0-21B3EE5959C0Q53883435-A5591C71-B205-4438-97EA-C0E3063CEBC0Q55012882-365C1AAF-3E36-41F2-AA5B-9467CE2FEAB2Q58801546-DDEF5725-9A44-4185-BDE8-CA1BA84913C5Q59093422-4504F6D7-E434-4FCC-BDF6-798947FE84C7
P2860
Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Targeting the tumor microenvir ...... e responses and immunotherapy.
@en
type
label
Targeting the tumor microenvir ...... e responses and immunotherapy.
@en
prefLabel
Targeting the tumor microenvir ...... e responses and immunotherapy.
@en
P2093
P2860
P50
P356
P1433
P1476
Targeting the tumor microenvir ...... e responses and immunotherapy.
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDW168
P577
2016-04-10T00:00:00Z